Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen H Costenbader

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
Current Opinion in Rheumatology|July 19, 2016
Environmental exposures and the development of systemic lupus erythematosusMedha Barbhaiya, Karen H Costenbader
Clinical Rheumatology|February 14, 2007
Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL)Jennifer K King, Karen H Costenbader
The Journal of Family Practice|July 4, 2007
Treatment and management of early RA: A primary care primerKaren H Costenbader, David S Kountz
Arthritis Research & Therapy|June 26, 2003
SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosusKaren H Costenbader, Matthew H Liang
Kidney International|June 27, 2016
Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspectivePaul J Hoover, Karen H Costenbader
Southern Medical Journal|June 16, 2005
Statin therapy in rheumatoid arthritisKaren H Costenbader, Jonathan S Coblyn
Autoimmunity|December 24, 2005
Cigarette smoking and systemic lupus erythematosus: a smoking gun?Karen H Costenbader, Elizabeth W Karlson
Arthritis Research & Therapy|March 18, 2006
Epstein-Barr virus and rheumatoid arthritis: is there a link?Karen H Costenbader, Elizabeth W Karlson
Nature Reviews. Rheumatology|February 4, 2010
Epidemiology: Interpreting studies of interactions between RA risk factorsElizabeth W Karlson, Karen H Costenbader
Seminars in Arthritis and Rheumatism|June 23, 2022
Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosusJoyce C Chang, Karen H Costenbader
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
Current Opinion in Rheumatology|July 19, 2016
Environmental exposures and the development of systemic lupus erythematosusMedha Barbhaiya, Karen H Costenbader
Clinical Rheumatology|February 14, 2007
Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL)Jennifer K King, Karen H Costenbader
The Journal of Family Practice|July 4, 2007
Treatment and management of early RA: A primary care primerKaren H Costenbader, David S Kountz
Arthritis Research & Therapy|June 26, 2003
SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosusKaren H Costenbader, Matthew H Liang
Kidney International|June 27, 2016
Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspectivePaul J Hoover, Karen H Costenbader
Southern Medical Journal|June 16, 2005
Statin therapy in rheumatoid arthritisKaren H Costenbader, Jonathan S Coblyn
Autoimmunity|December 24, 2005
Cigarette smoking and systemic lupus erythematosus: a smoking gun?Karen H Costenbader, Elizabeth W Karlson
Arthritis Research & Therapy|March 18, 2006
Epstein-Barr virus and rheumatoid arthritis: is there a link?Karen H Costenbader, Elizabeth W Karlson
Nature Reviews. Rheumatology|February 4, 2010
Epidemiology: Interpreting studies of interactions between RA risk factorsElizabeth W Karlson, Karen H Costenbader
Seminars in Arthritis and Rheumatism|June 23, 2022
Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosusJoyce C Chang, Karen H Costenbader
Pageof 27